AML CLINICAL CARE TOOLKIT INTRODUCTION

Acute myeloid leukemia (AML) remains a significant challenge for both patients and clinicians. While advances in genomic and molecular assessments have enhanced our understanding of AML, many patients still experience poor treatment outcomes. The advent of targeted therapies, informed by these assessments, offers hope in improving overall survival and quality of life. As novel therapies rapidly transform treatment paradigms, oncologists and other clinicians must stay current with the latest clinical updates and best practices in AML.

This clinical online resource equips clinicians to optimize AML management by offering key insights and practical resources. It covers AML’s pathophysiology, epidemiology, risk factors, and guidance on genetic and molecular assessments to inform treatment decisions. Clinicians will find updates on the latest therapies, relevant clinical data, and best practices for monitoring and managing adverse events, with emphasis on individualized care and strategies for tailoring treatments based on patient- and disease-specific factors that foster shared decision-making.